Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating promising results in the management of type 2 diabetes. This synthetic peptide duplicates the actions of naturally occurring GLP-1, a https://bookmark-rss.com/story20663389/retasturtide-a-novel-glp-1-receptor-agonist-for-type-2-diabetes